DSM-FIRMENICH AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.5 EUR | -1.87% |
|
0.00% | 0.00% |
| Jul. 01 | New semester, new state of mind |  |
| Jun. 26 | DSM-Firmenich Unit Issues EUR800 Million Bond | MT |
| Sales 2024 * | 12.59B 13.73B | Sales 2025 * | 13.26B 14.46B | Capitalization | 28.81B 31.41B |
|---|---|---|---|---|---|
| Net income 2024 * | 460M 502M | Net income 2025 * | 793M 865M | EV / Sales 2024 * | 2.52 x |
| Net Debt 2024 * | 2.86B 3.12B | Net Debt 2025 * | 2.6B 2.83B | EV / Sales 2025 * | 2.37 x |
| P/E ratio 2024 * |
62.6
x | P/E ratio 2025 * |
36.3
x | Employees | - |
| Yield 2024 * |
2.31% | Yield 2025 * |
2.3% | Free-Float | 25.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on DSM-Firmenich AG
More press releases
More news
| Current month | +2.94% | ||
| 1 month | +8.25% |
1 week
10.20
10.90
1 month
9.2510.90
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
| Director/Board Member | 62 | 23-01-31 |
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 10.5 | -1.87% |
| 24-07-15 | 10.7 | -1.83% |
| 24-07-12 | 10.9 | +1.87% |
| 24-07-11 | 10.7 | +1.90% |
| 24-07-10 | 10.5 | 0.00% |
Delayed Quote Börse Stuttgart, July 16, 2024 at 10:33 am EDT
More quotes
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
2024-07-30
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
108.6
EUR
Average target price
123
EUR
Spread / Average Target
+13.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.70% | 947B | |
| +2.43% | 244B | |
| +27.60% | 178B | |
| +4.18% | 142B | |
| +86.33% | 111B | |
| -3.23% | 75.64B | |
| -5.50% | 57.17B | |
| +142.32% | 41.04B | |
| +44.05% | 37.54B |
- Stock Market
- Equities
- DSFIR Stock
- ZX61 Stock
